Law360, New York (February 03, 2010, 12:48 PM ET) -- Nipro Corp. revealed Wednesday that it was set to fork out $215 million to acquire diabetes testing supply maker Home Diagnostics Inc., a move that will allow the Japanese medical device manufacturer to launch its pump products in the U.S. market.
The two companies said they had signed a definitive merger agreement under which Nipro will acquire all outstanding shares of Home Diagnostics’ common stock for a cash purchase price of $11.50 per share.
The offer price represents an approximately 90 percent premium to the closing...
Nipro To Snap Up Home Diagnostics For $215M
To view the full article, take a free trial now.
